The score is driven primarily by solid financial stability from a debt-free balance sheet, offset by weak cash flow (negative operating and deeply negative free cash flow). Technicals are neutral-to-mixed, while valuation is reasonable with a moderate dividend yield and mid-range P/E.
Positive Factors
Debt-free balance sheet
The company carries essentially no financial leverage, materially reducing refinancing and solvency risk and providing long-term financial flexibility. A sizable equity cushion (¥5.7bn of equity vs ¥8.5bn assets) helps absorb downturns and supports strategic investments without immediate liquidity stress.
High product gross margins
A roughly 76% gross margin indicates strong unit economics on product sales, enabling the business to fund marketing, counseling and salon services while retaining pricing power. High product margins are a durable competitive asset that supports long-term profitability if operating cost control improves.
Service-driven recurring revenue model
The blended model—product sales supported by in-person counseling and salon services—creates customer stickiness and repeat purchase streams. Physical service touchpoints foster higher lifetime value, cross-sell opportunities and differentiation versus pure e-commerce peers, aiding durable revenue retention.
Negative Factors
Weak cash generation
Operating cash flow weakness and persistently negative free cash flow signal the company is not self-funding its operations and investments. Continued negative FCF raises execution and financing risk: despite no debt, the firm may need external capital for capex, store upkeep or to sustain dividends, limiting strategic optionality.
Thin, volatile profitability
Reported margins are very thin and earnings have been volatile, with prior meaningful losses. Low operating and net margins leave little buffer against demand declines or cost increases, making earnings durability weak and reducing the company's ability to consistently generate return for shareholders over time.
Low returns on equity
ROE near 2.4% after recent negative years indicates the company is not efficiently converting its equity base into profits. Low and inconsistent ROE constrains long-term shareholder value creation and suggests capital allocation or operational execution issues unless margins and cash conversion sustainably improve.
C'BON COSMETICS Co., Ltd. (4926) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥5.84B
Dividend Yield1.68%
Average Volume (3M)1.75K
Price to Earnings (P/E)24.4
Beta (1Y)0.18
Revenue Growth8.46%
EPS GrowthN/A
CountryJP
Employees694
SectorConsumer Defensive
Sector Strength42
IndustryHousehold & Personal Products
Share Statistics
EPS (TTM)-9.06
Shares Outstanding4,281,200
10 Day Avg. Volume1,490
30 Day Avg. Volume1,753
Financial Highlights & Ratios
PEG Ratio-0.06
Price to Book (P/B)0.84
Price to Sales (P/S)0.54
P/FCF Ratio-5.15
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
C'BON COSMETICS Co., Ltd. Business Overview & Revenue Model
Company DescriptionC'BON COSMETICS Co.,Ltd. manufactures and sells cosmetics, quasi-drugs, and beauty appliance products. It offers various products, such as cleansing, lotion, cream, face wash, serum, and makeup base products. The company was founded in 1966 and is headquartered in Kawasaki, Japan.
How the Company Makes MoneyC'BON COSMETICS Co., Ltd. generates revenue through the direct sale of its cosmetics products, which include skincare creams, lotions, and other personal care items. The company primarily sells its products through a network of retail stores, online platforms, and beauty salons. Revenue is largely driven by consumer demand for high-quality skincare solutions and the company's ability to maintain strong relationships with retail partners. Additionally, C'BON COSMETICS may engage in strategic partnerships with other brands or entities to expand its market reach and enhance its product offerings. The company's earnings are significantly influenced by its brand reputation, product innovation, and effective marketing strategies.
Balance sheet strength is a key positive (no debt and solid equity cushion), but operating quality is mixed: profitability rebounded in 2025 to positive net and operating income with thin margins, while cash generation is a major weakness with negative operating cash flow and sharply negative free cash flow in 2025.
Income Statement
56
Neutral
Revenue has been broadly stable with a modest rebound in 2025 (+2.76% YoY) after declines in 2023 and a flat 2024. Profitability improved materially in 2025, returning to positive net income (¥136m) and positive operating profit, but margins remain thin (net margin ~1.5%, operating margin ~1.6%), well below the stronger gross margin profile (~76%). Results also show meaningful volatility, with sizable losses in 2020–2021 and again in 2023, suggesting earnings are not yet consistently durable.
Balance Sheet
86
Very Positive
The balance sheet is conservatively positioned with essentially no financial leverage (debt-to-equity near zero and total debt at ¥0 in 2025), which materially reduces refinancing and solvency risk. Equity remains large relative to the asset base (¥5.7bn equity vs. ¥8.5bn assets in 2025), providing a cushion through downturns. The main weakness is low and volatile returns on equity (about 2.4% in 2025 following negative returns in 2023–2024), indicating the company has not been consistently converting its capital base into attractive earnings.
Cash Flow
34
Negative
Cash generation is the key pressure point. Operating cash flow turned negative in 2025 (−¥43m) after being positive in 2024 and 2022, indicating weaker cash conversion despite improved reported earnings. Free cash flow is consistently negative across most years and was sharply negative in 2025 (−¥927m), pointing to heavy cash outflows that are not being self-funded by operations. While free cash flow improved in 2024 versus 2023, the overall pattern suggests elevated ongoing cash needs and higher execution risk if negative free cash flow persists.
Breakdown
TTM
Mar 2025
Mar 2024
Mar 2023
Mar 2022
Mar 2021
Income Statement
Total Revenue
9.02B
8.84B
8.50B
8.53B
9.15B
9.10B
Gross Profit
6.91B
6.74B
6.40B
6.34B
7.10B
6.92B
EBITDA
404.41M
292.59M
168.64M
-92.22M
329.61M
-345.64M
Net Income
253.04M
136.27M
-26.35M
-421.77M
44.87M
-621.87M
Balance Sheet
Total Assets
8.67B
8.52B
8.81B
8.84B
9.56B
9.56B
Cash, Cash Equivalents and Short-Term Investments
2.54B
2.65B
3.63B
3.98B
2.80B
2.32B
Total Debt
0.00
0.00
4.24M
13.27M
22.30M
25.20M
Total Liabilities
3.00B
2.82B
3.15B
3.13B
3.36B
1.97B
Stockholders Equity
5.67B
5.70B
5.66B
5.71B
6.20B
7.60B
Cash Flow
Free Cash Flow
0.00
-926.52M
-313.38M
-700.71M
321.35M
-829.87M
Operating Cash Flow
0.00
-43.16M
278.19M
-81.47M
433.37M
-694.00M
Investing Cash Flow
0.00
-849.16M
-581.94M
1.35B
44.91M
161.38M
Financing Cash Flow
0.00
-90.22M
-31.20M
-91.29M
-6.73M
-6.80M
C'BON COSMETICS Co., Ltd. Technical Analysis
Technical Analysis Sentiment
Positive
Last Price1188.00
Price Trends
50DMA
1262.46
Positive
100DMA
1229.68
Positive
200DMA
1192.77
Positive
Market Momentum
MACD
25.84
Negative
RSI
82.25
Negative
STOCH
81.90
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4926, the sentiment is Positive. The current price of 1188 is below the 20-day moving average (MA) of 1311.00, below the 50-day MA of 1262.46, and below the 200-day MA of 1192.77, indicating a bullish trend. The MACD of 25.84 indicates Negative momentum. The RSI at 82.25 is Negative, neither overbought nor oversold. The STOCH value of 81.90 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:4926.
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 30, 2025